Federal Bid

Last Updated on 07 Jan 2021 at 5 PM
Combined Synopsis/Solicitation
Rockville Maryland

NanoBret cellular activity assay, for 26 compounds, against LATS1 and AKT

Solicitation ID 21-001345
Posted Date 07 Jan 2021 at 5 PM
Archive Date 01 Feb 2020 at 5 AM
NAICS Category
Product Service Code
Set Aside No Set-Aside Used
Contracting Office National Institutes Of Health Ncats
Agency Department Of Health And Human Services
Location Rockville Maryland United states 20850

This order provides for the testing of 26 compounds against the AKT1 and LATS1 compounds in a NanoBRET target Engagement Intracellular Kinase Assay. This testing will inform on kinase inhibitory activity in our compound series, and will facilitate further optimization and development of these AKT1 / LATS1 compounds as well as potential treatments. 

Bid Protests Not Available

Similar Past Bids

Bethesda Maryland 07 Sep 2022 at 11 AM
Malvern Pennsylvania 11 Jan 2024 at 10 PM
Malvern Pennsylvania 17 Jan 2024 at 5 PM
Location Unknown 18 May 2022 at 1 PM

Similar Opportunities